Brief: Altamira Therapeutics Provides Business Update And First Half 2022 Financial Results
30/11/2022 14:41
Nov 30 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS PROVIDES BUSINESS UPDATE AND FIRST
HALF
2022 FINANCIAL RESULTS
* ALTAMIRA THERAPEUTICS LTD - EXPECTS ITS TOTAL CASH NEED
FOR
FUNDING OPERATIONS IN 2022 TO BE IN RANGE OF CHF 12.0 TO 13.0
MILLION
Source text for Eikon: ID:nGNX5QGlWF
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering